Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals

• Published in: The Canadian Journal of Infectious Diseases & Medical Microbiology 2007-09, Vol.18 (5), p.293-303
• Main Authors: Côté, Pierre, Baril, Jean-Guy, Hébert, Marie-Nicole, Klein, Marina, Lalonde, Richard, Poliquin, Marc, Rouleau, Danielle, Therrien, Rachel, Vézina, Sylvie, Willems, Bernard, Dion, Harold, Junod, Patrice, Lapointe, Normand, Lévesque, Dominic, Pinault, Lyse, Tremblay, Cécile, Trottier, Benoît, Trottier, Sylvie, Tsoukas, Chris, Piché, Alain
• Format: Article
• Language: English
• Subjects: Special
• ISSN: 1712-9532; 1918-1493; 1180-2332
• DOI: 10.1155/2007/631054

Concomitant HIV and hepatitis C virus (HCV) is a common yet complex coinfection. The present document is a practical guide for treating HCV infection in people coinfected with HIV. Effective antiretroviral therapies have prolonged survival rates for HIV-infected people over the past decade, which have made latent complications of HCV major causes of morbidity and mortality in these patients. Advances in the treatment of HCV (eg, combined pegylated interferon and ribavirin) offer the possibility of eradicating HCV infection in coinfected persons. The treatment of HCV must be considered in all cases. Intensive management of the adverse effects of HCV treatment is one of the factors for the success of these therapies. HCV eradication is predicted to decrease the mortality associated with coinfection and reduce the toxicity of HIV treatment.